Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Starmer says UK to recognize Palestinian state if...
‘Critical’ closed-door congressional huddle focuses on growing antisemitism...
Trump’s CDC pick confirmed—but her pro-vaccine stance may...
Trump pick Emil Bove confirmed as federal judge...
From Gaza to Greenland, Macron breaks with Trump...
Schumer calls on FBI to conduct counterintelligence threat...
Biden ‘Politburo’ member Steve Ricchetti to appear before...
Trump looks to skip G20 summit in South...
Backlash against Sydney Sweeney ‘jeans/genes’ ad gets mocked...
Biden ‘Politburo’ member Steve Ricchetti appears before House...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

Russia Restricts US Uranium Exports, Retaliating to American Ban

by admin November 19, 2024
November 19, 2024
Russia Restricts US Uranium Exports, Retaliating to American Ban

The Russian government has imposed temporary restrictions on enriched uranium exports to the US.

Announced on November 15, the move follows the US’ decision toban imports of Russian uranium.

While the US legislation went into effect in August, it allows for waivers to address potential supply disruptions through 2027. The new Russian policy introduces uncertainty during this time period.

According to the US Energy Information Administration, Russia provided 27 percent of the enriched uranium used in American reactors in 2023. Globally, the country accounts for about 44 percent of enrichment capacity.

To illustrate, Urenco — a consortium-owned company operating the only US-based enrichment facility in New Mexico — supplies only about one-third of the country’s enriched uranium.

While the restrictions from Russia don’t leave the US without recourse, as utilities typically secure uranium supply years in advance, analysts are warning that continued restrictions could pose challenges from 2025 onward.

Market responses to the news were swift. Cameco (TSX:CCO,NYSE:CCJ), a leading uranium producer, emphasized in a statement to Bloomberg the need for coordinated western action to reduce reliance on Russian nuclear fuel.

Shares of uranium companies reflected the heightened supply concerns, with Cameco’s share price jumping as much as 6.5 percent on the TSX on November 15. US-based uranium firms such as Uranium Energy (NYSEAMERICAN:UEC) and Ur-Energy (TSX:URE,NYSEAMERICAN:URG) also experienced upticks that day.

Meanwhile, shares of Centrus Energy (NYSEAMERICAN:LEU), the biggest US trader of Russian enriched uranium, fell by close to 9 percent on November 15 as investors weighed the potential impacts of the restrictions.

The company said it had not received details surrounding Russia’s decree and was assessing the implications.

Centrus also noted that it has contingency plans to mitigate near-term impacts should Russia’s state-owned uranium supplier, Tenex, face challenges fulfilling existing agreements. Centrus is one company that has received a waiver from the Biden administration to continue importing Russian uranium despite the US ban.

Constellation Energy (NASDAQ:CEG) has also received a waiver, and other requests are reportedly pending.

Russia’s actions come amid broader geopolitical tensions and follow President Vladimir Putin’s earlier call for the country to consider restricting exports of uranium, titanium and nickel in response to western sanctions.

At the same time, the US government has been actively working to rebuild its uranium enrichment capabilities. A multibillion-dollar initiative to expand these operations is underway, but progress has been slow.

Overall, the US is currently looking triple its nuclear capacity by 2050, with plans to add 200 gigawatts of new nuclear energy through reactor builds, reactivations and upgrades to existing facilities.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Mawson Finland Limited Presents Downhole EMGeophysics: Multiple Deep Conductors Newly Identified at Rajapalot
next post
Australian Ethics Committee Approval to Expand PD-L1 Nanobody (RAD204) Phase 1 Trial in Multiple Tumor Types

You may also like

Brien Lundin: Gold’s Ultimate Move Still to Come,...

March 6, 2025

Experts: Battery and Precious Metals Emerging as New...

February 24, 2025

Top 10 Aluminum-producing Countries (Updated 2024)

August 15, 2024

Constellation to Revive Three Mile Island, Sell Power...

September 24, 2024

Crypto Market Recap: South Korea Dismisses Bitcoin Reserve...

March 17, 2025

Silver Price Surges to US$36, Marking 13 Year...

June 6, 2025

American Pacific Gains Full Ownership of Palmer VMS...

November 20, 2024

Sun Summit Commences Drilling and Provides Exploration Update...

July 14, 2025

2024 Annual Results – Capacity ramp-up, economies of...

February 28, 2025

Cizzle Brands: A Sports Nutrition Company Leading the...

January 15, 2025

Recent Posts

  • Starmer says UK to recognize Palestinian state if Israel doesn’t agree to ceasefire, Hamas must ‘disarm’
  • ‘Critical’ closed-door congressional huddle focuses on growing antisemitism in US, Mamdani’s rise
  • Trump’s CDC pick confirmed—but her pro-vaccine stance may clash with RFK Jr.’s agenda
  • Trump pick Emil Bove confirmed as federal judge after furious Democrat walkout, whistleblower complaints
  • From Gaza to Greenland, Macron breaks with Trump on global flashpoints

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (845)
    • Investing (2,651)
    • Politics (3,267)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.